Afuco™ Anti-Human FGFR2 ADCC Therapeutic Antibody (BAY 1179470), ADCC Enhanced
Anti-FGFR2 ADCC Enhanced Antibody (BAY 1179470) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel fibroblast growth factor receptor 2 (FGFR2) directed antibody used for cancer therapy. FGFR2 is expressed in a range of tumor types such as gastric, breast, HNSCC, pancreatic and ovarian cancers. FGFR2 has been described to promote tumor growth and survival and play a role in chemotherapy resistance.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-271CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FGFR2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Open under aseptic conditions. |